Sarah Kattakuzhy (left) and Elana Rosenthal
Adrianne Hammershaimb
Physician researchers had been acknowledged as Leaders in Health Care and 40 Under 40 Award winners.
BALTIMORE, MARYLAND, UNITED STATES, November 2, 2022 /EINPresswire.com/ — Three University of Maryland School of Medicine (UMSOM) doctor researchers had been acknowledged when the Baltimore Business Journal introduced its Leaders in Health Care and 40 Under 40 Award winners.
Sarah Kattakuzhy, MD, and Elana Rosenthal, MD, of UMSOM’s Institute of Human Virology (IHV), obtained Leaders in Health Care awards for his or her roles in spearheading a neighborhood outreach program for marginalized members of society. Drs. Kattakuzhy and Rosenthal additionally had been twin honorees within the Health Care Outcomes class, which acknowledges contributions made by these main a coordinated effort to enhance affected person outcomes and neighborhood wellness.
Adrianne Hammershaimb, MD, MS, of UMSOM’s Center for Vaccine Development and Global Health (CVD) and the Department of Pediatrics, was chosen as a 40 Under 40 recipient after taking part in a key function within the Moderna and Novavax COVID-19 vaccine trials in Maryland and main a research that knowledgeable the Center for Disease Control and Prevention’s (CDC) messaging on administering the vaccine to youngsters.
Drs. Kattakuzhy and Rosenthal had been honored on the Baltimore Business Journal’s Leaders in Health Care occasion on Thursday, October 6, at Martin’s Valley Mansion in Cockeysville, MD, whereas Dr. Hammershaimb might be acknowledged on the 40 Under 40 occasion on Thursday, November 17 on the Marriott Owings Mills Metro Center in Owings Mills, MD.
“These awards reflect the breadth of UMSOM’s reach from patient care in our local community to our research influencing nationwide policy guidelines for an international pandemic,” stated Mark T. Gladwin, MD, Vice President for Medical Affairs at University of Maryland, Baltimore, and the John Z. and Akiko Ok. Bowers Distinguished Professor and Dean at UMSOM. “I could not be prouder of the work performed by our own clinician researchers in their quest to address several of the greatest generational challenges of our time.”
Drs. Kattakuzhy and Rosenthal maintain management roles with the Research Initiative on Infectious Diseases and Substance Abuse (RIIS) program inside UMSOM’s IHV. This program serves members of the neighborhood who sometimes slip by means of the healthcare cracks, together with individuals who inject medication, intercourse employees, transgender people, and other people experiencing homelessness. RIIS’ major objective is to discover the intersection of infections and substance abuse in marginalized populations.
Dr. Kattakuzhy, an Associate Professor of Medicine and the Baltimore RIIS Director, and Dr. Rosenthal, an Assistant Professor of Medicine and the Washington, D.C. RIIS Director, have been concerned with this system since 2014.
“My colleagues and I at UMSOM’s Institute of Human Virology are proud of Drs. Kattakuzhy and Rosenthal and their commitment to advance public health in our local communities,” stated Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the UMSOM’s Institute of Human Virology, and Co-Founder and Chair of the Scientific Leadership Board of the Global Virus Network (GVN). “Their success extends beyond our region and impacts the field of clinical research broadly.”
Led by Drs. Kattakuzhy and Rosenthal, the RIIS workforce supplies on-site therapy for infectious ailments comparable to hepatitis C, HIV therapy and prevention, drugs for opioid use dysfunction, and gender-affirming hormone remedy. Patients can also obtain hurt discount providers comparable to needle and syringe alternate, whereas partaking with suppliers who’re non-judgmental and sympathetic. In addition to offering care in Greater Baltimore and Washington D.C., RIIS serves at-risk populations on the Eastern Shore through a cell van.
While offering medical care is a major purpose of the RIIS program, analysis can also be an integral facet of the initiative. Through medical analysis, RIIS goals to grasp and enhance how care is delivered to marginalized populations. The workforce determines gaps in care, after which plans, implements, and evaluates supply strategies.
RIIS additionally has made a constructive influence by means of this system’s skill to adapt to the altering wants of the neighborhood. When many individuals misplaced entry to their physicians on the onset of the COVID-19 pandemic in 2020, this system assisted these people in receiving routine care, together with HIV medicine, and gender-affirming hormone remedy for transgender people.
“Drs. Kattakuzhy and Rosenthal well deserve this award. The business of health care is taking good care of patients, especially those who are marginalized. In this regard, they both have inspired us all through their leadership, compassion, and dedication to the most needed communities in Maryland,” stated Shyam Kottilil, MBBS, PhD, Professor of Medicine on the UMSOM and Director of UMSOM’s Institute of Human Virology (IHV) Division of Clinical Care and Research.
Dr. Hammershaimb started her fellowship coaching at UMSOM shortly earlier than the primary instances of COVID-19 had been recognized in Maryland. Dr. Hammershaimb recognized and reported some of the state’s earliest instances of Multisystem Inflammatory Syndrome in Children (MIS-C) – a illness in youngsters associated to COVID-19 – and rapidly turned a extremely sought-after useful resource for the most recent developments in prevention, testing, and therapy for COVID-19 in youngsters and MIS-C. She helped implement hospital insurance policies, whereas additionally educating medical college students and pediatricians throughout the University of Maryland Medical System and locally on the subjects of COVID-19 in youngsters and MIS-C.
Additionally, Dr. Hammershaimb helped lead the Moderna and Novavax vaccine trials at UMSOM’s satellite tv for pc website at CASA de Maryland in Prince George’s County, offering outreach to the Latinx neighborhood and making certain that the trial was inclusive of Latinx Marylanders. This work was important because the Hispanic neighborhood in Maryland has historically not been concerned in medical analysis and was disproportionately affected by the pandemic.
While offering key assist to the vaccine trials, Dr. Hammershaimb concurrently dove into analysis associated to COVID-19 vaccine acceptance, work that caught the eye of the nation’s policymakers and public well being leaders and was utilized in discussions of how you can appropriately message the general public on the subject. Earlier this yr, Dr. Hammershaimb offered her work to the CDC Advisory Committee on Immunization Practices COVID-19 Working Group, which influenced how the group disseminated info and proposals to the general public on the COVID-19 vaccine in youngsters.
Vanessa McMains
Institute of Human Virology
+1 4438756099
e-mail us right here
